In general, our datasets include luminal A (T47D, MCF-7, ZR751), triple negative (MDA-MB-231, MDA-MB-157 and MDA-MB-436) and HER2+ (MDA-MB-453) breast cancer cell lines treated with at least one of indole-3-carbinol, Withaferin A, CKI and Actein. This evidence concerns the gene ERBB2 and breast carcinoma.